Literature DB >> 29072492

Strategies for reducing ovarian dose in volumetric modulated arc therapy (VMAT) for postoperative uterine cervical cancer.

Ueda Yoshihiro1,2, Ohira Shingo1,3, Isono Masaru1, Miyazaki Masayoshi1, Konishi Koji1, Kamiura Shoji4, Sumida Iori2, Ogawa Kazuhiko2, Teshima Teruki1.   

Abstract

OBJECTIVE: To reduce the ovarian dose with volumetric modulated arc therapy (VMAT), an original VMAT was designed with two types of arcs to restrict angles and fields (R-VMAT).
METHODS: The subjects were 11 patients who underwent ovarian transposition with clips left by a surgeon. Three methods, intensity-modulated radiotherapy (IMRT), standard VMAT (S-VMAT) and R-VMAT, were optimized for assessment of the ovarian dose with the target coverage kept high.
RESULTS: The homogeneity and conformity indexes for the planning target volume (PTV) were similar for the three methods. However, the average ± SD of the ovarian mean dose (OMD) was 5.0 ± 1.5, 4.9 ± 1.9 and 3.5 ± 1.4 Gy, and the percentage of ovarian volume exceeding 5 Gy (V5) was 41.5 ± 34.1%, 34.1 ± 38.05% and 8.4 ± 20.5% for IMRT, S-VMAT and R-VMAT, respectively. The OMD and V5 were significantly smaller for R-VMAT than for the other plans (p < 0.01). Correlation values between the OMD and the lateral distance from the ovaries to the PTV surface were 0.86, 0.81 and 0.82 for IMRT, S-VMAT and R-VMAT, respectively.
CONCLUSION: These findings suggest that R-VMAT delivered the lowest dose to the ovaries. To reduce the OMD to less than 3 Gy, ovaries should be transposed laterally 6.1 cm away from the PTV surface when R-VMAT is used. Advances in knowledge: When organs with high susceptibility to radiation, such as ovaries, are near the PTV, R-VMAT is superior to IMRT and S-VMAT.

Entities:  

Mesh:

Year:  2017        PMID: 29072492      PMCID: PMC5966198          DOI: 10.1259/bjr.20160777

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  23 in total

1.  Multileaf collimator end leaf leakage: implications for wide-field IMRT.

Authors:  N Hardcastle; P Metcalfe; A Ceylan; M J Williams
Journal:  Phys Med Biol       Date:  2007-10-11       Impact factor: 3.609

2.  Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy.

Authors:  Laura Masi; Raffaela Doro; Virginia Favuzza; Samantha Cipressi; Lorenzo Livi
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

3.  A new metric for assessing IMRT modulation complexity and plan deliverability.

Authors:  Andrea L McNiven; Michael B Sharpe; Thomas G Purdie
Journal:  Med Phys       Date:  2010-02       Impact factor: 4.071

4.  A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.

Authors:  Takafumi Toita; Tatsuya Ohno; Yuko Kaneyasu; Takashi Uno; Ryouichi Yoshimura; Takeshi Kodaira; Kazuhisa Furutani; Goro Kasuya; Satoshi Ishikura; Toshiharu Kamura; Masahiro Hiraoka
Journal:  Jpn J Clin Oncol       Date:  2010-02-04       Impact factor: 3.019

5.  Feasibility study of volumetric modulated arc therapy with constant dose rate for endometrial cancer.

Authors:  Ruijie Yang; Junjie Wang; Feng Xu; Hua Li; Xile Zhang
Journal:  Med Dosim       Date:  2013-05-10       Impact factor: 1.482

6.  Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies.

Authors:  A J Mundt; J C Roeske; A E Lujan; S D Yamada; S E Waggoner; G Fleming; J Rotmensch
Journal:  Gynecol Oncol       Date:  2001-09       Impact factor: 5.482

7.  Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy.

Authors:  Jong Ha Hwang; Heon Jong Yoo; Sae Hyun Park; Myong Cheol Lim; Sang-Soo Seo; Sokbom Kang; Joo-Young Kim; Sang-Yoon Park
Journal:  Fertil Steril       Date:  2012-03-30       Impact factor: 7.329

8.  Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome.

Authors:  Sushil Beriwal; Dwight E Heron; Hayeon Kim; Gwendolyn King; Jeffrey Shogan; Sanjeev Bahri; Kristina Gerszten; Joe Lee; Joseph Kelley; Robert P Edwards
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-25       Impact factor: 7.038

9.  Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy.

Authors:  David Palma; Emily Vollans; Kerry James; Sandy Nakano; Vitali Moiseenko; Richard Shaffer; Michael McKenzie; James Morris; Karl Otto
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

10.  Can clinically relevant dose errors in patient anatomy be detected by gamma passing rate or modulation complexity score in volumetric-modulated arc therapy for intracranial tumors?

Authors:  Shingo Ohira; Yoshihiro Ueda; Masaru Isono; Akira Masaoka; Misaki Hashimoto; Masayoshi Miyazaki; Masaaki Takashina; Masahiko Koizumi; Teruki Teshima
Journal:  J Radiat Res       Date:  2017-09-01       Impact factor: 2.724

View more
  6 in total

1.  Dosimetric impact of rotational setup errors in volumetric modulated arc therapy for postoperative cervical cancer.

Authors:  Katsutomo Tsujii; Yoshihiro Ueda; Masaru Isono; Masayoshi Miyazaki; Teruki Teshima; Masahiko Koizumi
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

2.  Study on the ability of 3D gamma analysis and bio-mathematical model in detecting dose changes caused by dose-calculation-grid-size (DCGS).

Authors:  Han Bai; Sijin Zhu; Xingrao Wu; Xuhong Liu; Feihu Chen; Jiawen Yan
Journal:  Radiat Oncol       Date:  2020-07-06       Impact factor: 3.481

3.  Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy.

Authors:  Takaya Yamamoto; Rei Umezawa; Hideki Tokunaga; Masaki Kubozono; Maiko Kozumi; Noriyoshi Takahashi; Haruo Matsushita; Noriyuki Kadoya; Kengo Ito; Kiyokazu Sato; Keita Tsuji; Muneaki Shimada; Keiichi Jingu
Journal:  J Radiat Res       Date:  2020-05-22       Impact factor: 2.724

4.  Dosimetric comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy in patients with cervical cancer: a meta-analysis.

Authors:  Wei Bai; Changgui Kou; Weiying Yu; Yuanyuan Li; Wanqing Hua; Lei Yu; Jianfeng Wang
Journal:  Onco Targets Ther       Date:  2018-10-18       Impact factor: 4.147

5.  Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy.

Authors:  Xiao-Juan Lv; Xiao-Long Cheng; Ye-Qiang Tu; Ding-Ding Yan; Qiu Tang
Journal:  Radiat Oncol       Date:  2019-12-16       Impact factor: 3.481

6.  Significance of ovarian transposition in the preservation of ovarian function for young cervical cancer patients undergoing postoperative volumetric modulated radiotherapy.

Authors:  Hanzi Xu; Chang Guo; Xiuming Zhang; Yaqin Wu; Biqing Zhu; Emei Lu; Zhihua Sun; Dan He; Fei Deng; Juan Lv; Zhen Gong
Journal:  Ann Transl Med       Date:  2021-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.